Evidence map›Paper›PMID 30783185›Full record

ArticleScientific reports2019

Efficient system for upstream mRNA trans-splicing to generate covalent, head-to-tail, protein multimers.

Hiroaki Mitsuhashi, Sachiko Homma, Mary Lou Beermann, Satoshi Ishimaru, Hayato Takeda, Bryant K Yu, Kevin Liu, Swetha Duraiswamy, Frederick M Boyce, Jeffrey Boone Miller

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hiroaki MitsuhashiDepartment of Applied, Biochemistry School of Engineering, Tokai University Kanagawa, Yokohama, 259-1207, Japan. hmitsuhashi@tsc.u-tokai.ac.jp.
Sachiko HommaDepartment of Neurology, Boston University School of Medicine Boston, Massachusetts, 02118, USA.
Mary Lou BeermannDepartment of Neurology, Boston University School of Medicine Boston, Massachusetts, 02118, USA.
Satoshi IshimaruDepartment of Applied, Biochemistry School of Engineering, Tokai University Kanagawa, Yokohama, 259-1207, Japan.
Hayato TakedaDepartment of Applied, Biochemistry School of Engineering, Tokai University Kanagawa, Yokohama, 259-1207, Japan.
Bryant K YuDepartment of Neurology, Boston University School of Medicine Boston, Massachusetts, 02118, USA.
Kevin LiuDepartment of Neurology, Boston University School of Medicine Boston, Massachusetts, 02118, USA.
Swetha DuraiswamyDepartment of Neurology, Boston University School of Medicine Boston, Massachusetts, 02118, USA.
Frederick M BoyceDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts, 02114, USA.
Jeffrey Boone MillerDepartment of Neurology, Boston University School of Medicine Boston, Massachusetts, 02118, USA. millerjb@bu.edu.ORCID 0000-0001-5273-2201

Funding

Mechanisms of DUX4 mediated FSHD pathologyR01AR062587 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI JONES, PETER L · 2013 to 2024
$5.3M
Pathogenesis of Muscular DystrophiesR01AR060328 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MILLER, JEFFREY BOONE · 2012 to 2016
$2.5M
NIAMS NIH HHS R01 AR060328NIAMS NIH HHS R01 AR062587U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AR060328U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01AR062587
6 · The paper itself

Abstract

We present a plasmid-based system in which upstream trans-splicing efficiently generates mRNAs that encode head-to-tail protein multimers. In this system, trans-splicing occurs between one of two downstream splice donors in the sequence encoding a C-terminal V5 epitope tag and an upstream splice acceptor in the 5' region of the pCS2(+) host plasmid. Using deletion and fusion constructs of the DUX4 protein as an example, we found that this system produced trans-spliced mRNAs in which coding regions from independent transcripts were fused in phase such that covalent head-to-tail protein multimers were translated. For a cDNA of ~450 bp, about half of the expressed proteins were multimeric, with the efficiency of trans-splicing and extent of multimer expression decreasing as cDNA length increased. This system generated covalent heterodimeric proteins upon co-transfections of plasmids encoding separate proteins and did not require a long complementary binding domain to position mRNAs for trans-splicing. This plasmid-based trans-splicing system is adaptable to multiple gene delivery systems, and it presents new opportunities for investigating molecular mechanisms of trans-splicing, generating covalent protein multimers with novel functions within cells, and producing mRNAs encoding large proteins from split precursors.

Indexed as

Genetic EngineeringRNA, MessengerTrans-SplicingHEK293 CellsHeLa CellsHomeodomain ProteinsHumansPlasmidsDUX4L1 protein, humanHomeodomain ProteinsRNA, Messenger

Identifiers

PMID30783185
PMCPMC6381186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.